Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionCitigroup Inc
Latest Disclosed Ownership21,594 shares
Latest Disclosed Value $ 4,311,242
Citigroup Inc ownership in LGND / Ligand Pharmaceuticals Incorporated

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 21,594 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $4,311,242 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 18,292 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 18.05% during the quarter. The current value of the position is $5,061,634 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (LGND) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

LGND / Ligand Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,594 3,302 18.05 4,311 24.67 0.0018
2026-02-13 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 18,292 -3,095 -14.47 3,458 -8.71 0.0015
2025-11-10 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,387 -8,287 -27.93 3,788 12.30 0.0017
2025-08-11 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 29,674 -16 -0.05 3,373 8.07 0.0017
2025-05-12 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 29,690 1,702 6.08 3,122 4.10 0.0016
2025-02-12 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 27,988 2,408 9.41 2,999 17.11 0.0018
2024-11-12 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,580 11,107 76.74 2,560 110.01 0.0015
2024-08-12 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 14,473 1,211 9.13 1,219 25.80 0.0008
2024-05-10 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 13,262 816 6.56 969 9.12 0.0006
2024-02-09 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 12,446 3,669 41.80 889 69.14 0.0006
2023-12-06 2023-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 8,777 -7,295 -45.39 526 -54.66 0.0004
2023-11-09 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 8,777 -7,295 526 0.0002
2023-08-10 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 16,072 3,676 29.65 1,159 27.11 0.0008
2023-05-11 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 12,396 -572 -4.41 912 5.20 0.0006
2023-02-09 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 12,968 -29,394 -69.39 866 -76.26 0.0007
2022-11-10 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 42,362 5,723 15.62 3,648 11.59 0.0026
2022-08-10 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 36,639 12,701 53.06 3,269 21.39 0.0024
2022-05-12 2022-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 23,938 -18,198 -43.19 2,693 -58.62 0.0016
2022-02-10 2021-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 42,136 6,405 17.93 6,508 30.74 0.0035
2021-11-10 2021-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35,731 557 1.58 4,978 7.87 0.0029
2021-08-10 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 35,174 6,278 21.73 4,615 4.77 0.0028
2021-05-13 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 28,896 23,416 427.30 4,405 708.26 0.0028
2021-02-11 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 5,480 3,224 142.91 545 153.49 0.0003
2020-11-12 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 2,256 -14,690 -86.69 215 -88.65 0.0001
2020-08-12 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 16,946 -8,519 -33.45 1,895 2.32 0.0015
2020-05-12 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,465 9,958 64.22 1,852 14.53 0.0017
2020-02-12 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 15,507 -519 -3.24 1,617 1.38 0.0012
2019-11-08 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 16,026 1,553 10.73 1,595 -3.51 0.0013
2019-08-12 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 14,473 -5,640 -28.04 1,653 -34.61 0.0013
2019-05-13 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,113 -41,652 -67.44 2,528 -69.84 0.0024
2019-02-12 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 61,765 35,572 135.81 8,382 16.58 0.0085
2018-11-13 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 26,193 19,010 264.65 7,190 383.20 0.0064
2018-08-10 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 7,183 -19,670 -73.25 1,488 -66.45 0.0014
2018-05-11 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 26,853 -9,494 -26.12 4,435 -10.89 0.0037
2018-02-12 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 36,347 5,185 16.64 4,977 17.30 0.0040
2017-11-13 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 31,162 -1,113 -3.45 4,243 8.30 0.0035
2017-08-11 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 32,275 2,517 8.46 3,918 24.42 0.0035
2017-05-12 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 29,758 -54,953 -64.87 3,149 -63.41 0.0028
2017-02-10 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 84,711 69,343 451.22 8,607 448.92 0.0078
2016-11-10 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 15,368 9,340 154.94 1,568 118.08 0.0015
2016-08-12 2016-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,028 -6,992 -53.70 719 -48.42 0.0007
2016-05-13 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 13,020 -26,072 -66.69 1,394 -67.11 0.0016
2016-02-12 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 39,092 1,692 4.52 4,239 32.34 0.0042
2015-11-13 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 37,400 36,082 2,737.63 3,203 2,308.27 0.0030
2015-08-13 2015-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 1,318 -443 -25.16 133 -2.21 0.0001
2015-05-14 2015-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 1,761 -11,031 -86.23 136 -80.03 0.0001
2015-02-17 2014-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 12,792 2,839 28.52 681 45.51 0.0006
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 9,953 9,049 1,001.00 468 735.71 0.0004
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 904 -287 -24.10 56 -30.00 0.0001
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 1,191 -5,545 -82.32 80 -77.46 0.0001
2014-02-14 2013-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 6,736 2,687 66.36 355 102.86 0.0003
2013-11-14 2013-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 4,049 3,868 2,137.02 175 2,400.00 0.0002
2013-08-14 2013-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 181 181 7 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 12,500 331.03 1,243 350.36 n/a n/a n/a
2020-11-12 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 2,900 -62.82 276 -68.35 n/a n/a n/a
2020-08-12 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 7,800 -17.89 872 26.19 n/a n/a n/a
2020-05-12 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 9,500 -40.99 691 -58.84 n/a n/a n/a
2020-02-12 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 16,100 15.00 1,679 20.44 n/a n/a n/a
2019-11-08 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 14,000 636.84 1,394 542.40 n/a n/a n/a
2019-08-12 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 1,900 -65.45 217 -68.60 n/a n/a n/a
2019-05-13 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 5,500 -32.10 691 -37.12 n/a n/a n/a
2019-02-12 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 8,100 326.32 1,099 110.54 n/a n/a n/a
2018-11-13 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 1,900 -63.46 522 -51.53 n/a n/a n/a
2018-08-10 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 5,200 -55.17 1,077 -43.79 n/a n/a n/a
2018-05-11 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 11,600 300.00 1,916 382.62 n/a n/a n/a
2018-02-12 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 2,900 222.22 397 222.76 n/a n/a n/a
2017-11-13 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 900 -96.86 123 -96.47 n/a n/a n/a
2017-08-11 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW Call 28,700 4,000.00 3,484 4,608.11 n/a n/a n/a
2017-05-12 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW Call 700 -95.10 74 -94.91 n/a n/a n/a
2017-02-10 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW Call 14,300 429.63 1,453 426.45 n/a n/a n/a
2016-11-10 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW Call 2,700 276 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 6,300 5.00 627 9.62 n/a n/a n/a
2020-11-12 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 6,000 -48.28 572 -55.90 n/a n/a n/a
2020-08-12 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 11,600 90.16 1,297 192.12 n/a n/a n/a
2020-05-12 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 6,100 -77.74 444 -84.46 n/a n/a n/a
2020-02-12 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 27,400 44.21 2,858 51.14 n/a n/a n/a
2019-11-08 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 19,000 88.12 1,891 64.01 n/a n/a n/a
2019-08-12 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 10,100 -47.94 1,153 -52.73 n/a n/a n/a
2019-05-13 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 19,400 295.92 2,439 266.77 n/a n/a n/a
2019-02-12 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 4,900 -7.55 665 -54.30 n/a n/a n/a
2018-11-13 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 5,300 657.14 1,455 903.45 n/a n/a n/a
2018-08-10 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 700 -83.33 145 -79.11 n/a n/a n/a
2018-05-11 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 4,200 -36.36 694 -23.23 n/a n/a n/a
2018-02-12 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 6,600 -16.46 904 -15.99 n/a n/a n/a
2017-11-13 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 7,900 690.00 1,076 789.26 n/a n/a n/a
2017-08-11 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW Put 1,000 -60.00 121 -54.34 n/a n/a n/a
2017-05-12 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW Put 2,500 -75.00 265 -73.92 n/a n/a n/a
2017-02-10 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW Put 10,000 1,150.00 1,016 1,139.02 n/a n/a n/a
2016-11-10 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW Put 800 82 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.